Immunologically-mediated tumour cell apoptosis: The role of TRAIL in T cell and cytokine-mediated responses to melanoma

FORUM - Trends in Experimental and Clinical Medicine

Volumn 10, Issue 3, 2000, Pages 243-252

  Nguyen, T ^a   Thomas, W ^a   Zhang, X D ^a   Gray, C ^a   Hersey, P ^a  

^a NEWCASTLE MATER HOSPITAL   (Australia)

Author keywords

Apoptosis; CD4T cells; IFN ; IFN ; Melanoma; TRAIL

Indexed keywords

ALPHA2A INTERFERON; CALCIUM ION; CD14 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CELL SURFACE PROTEIN; CYTOKINE; FAS LIGAND; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN F(AB) FRAGMENT; INTERLEUKIN 2; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD3; PHYCOERYTHRIN; RHODAMINE; STREPTAVIDIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER STAGING; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA FLANKING REGION; DRUG EXPOSURE; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOTHERAPY; MELANOMA; MELANOMA CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME; TUMOR BIOPSY; TUMOR IMMUNOLOGY;

ANTIGENS, CD4; APOPTOSIS; CYTOKINES; HUMANS; IMMUNOTHERAPY; INTERFERON TYPE II; INTERFERON-ALPHA; LIGANDS; MELANOMA; SKIN NEOPLASMS; T-LYMPHOCYTES; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0034527878     PISSN: 11218142     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Spontaneous regression of malignant melanoma
2. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma
3. Current research on immunopathology of melanoma: Analysis of lymphocyte populations in relation to antigen expression and histological features of melanoma
4. Inflammatory cell infiltrates in human melanoma at different stages of tumor progression
5. Immunocytochemical analysis of the cellular infiltrate in primary regressing and non-regressing malignant melanoma
6. Effect of IFN-alpha on tumor-infiltrating mononuclear cells and regressive changes in metastatic malignant melanoma
7. + T cell-mediated cytotoxicity
8. CTL granules: Evolution of vesicles essential for combating virus infections
9. Decreased tumor surveillance in perforin-deficient mice
10. Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein
11. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors
12. TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas Ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells
13. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs
14. Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL
15. Natural killer (NK) cell-mediated cytotoxicity: Differential use of TRAIl and Fas ligand by immature and mature primary human NK cells
16. Regulation of APO-2 ligand/TRAIL expression in NK cells-involvement in NK cell-mediated cytotoxicity
17. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma
18. Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells
19. Temozolomide inhibits activation of NF-κB and sensitizes melanoma cells to TRAIL induced apoptosis
20. The proteasome inhibitor PS-341 in cancer therapy
21. Enhanced therapeutic efficacy of TRAIL/APO2L in combination with CPT-11 in the treatment of human tumor xenografts
22. Synergistic cytotoxicity and apoptosis by TRAIL and adriamycin against bladder cancer cells
23. TRAIL induced apoptosis of melanoma is associated with changes in mitochondrial membrane potential and perinuclear clustering of mitochondria
24. p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha
25. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy
26. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand
27. Relative resistance of fresh isolates of melanoma to TRAIL induced apoptosis